thiazoles has been researched along with thromboxane b2 in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (8.70) | 18.7374 |
1990's | 10 (21.74) | 18.2507 |
2000's | 23 (50.00) | 29.6817 |
2010's | 9 (19.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruneau, P; Crawley, GC; Edwards, MP; Foster, SJ; Girodeau, JM; Kingston, JF; McMillan, RM | 1 |
Benveniste, J; Coëffier, E; Desquand, S; Floch, A; Lefort, J; Maridonneau-Parini, I; Randon, J; Sedivy, P; Vargaftig, BB | 1 |
Adachi, M; Imai, T; Kamiya, I; Kobayashi, H; Nishikata, H; Okazawa, A; Satoh, H; Takahashi, T; Yamaguchi, H | 1 |
Robertson, DN; Smith, GM | 1 |
Handley, DA; Saunders, RN; Van Valen, RG | 1 |
Hsyu, PH; Koets, MD; Luderer, JR | 1 |
Hibi, S; Inoue, T; Kawahara, T; Kobayashi, N; Murakami, M; Numata, H; Okamoto, Y; Oketani, K; Shinoda, M; Tagami, K | 1 |
Albert, DH; Carter, GW; Grossman, JE; Kruse-Elliott, KT; Summers, JB; Zimmerman, JJ | 1 |
Frölich, JC; Stichtenoth, DO; Wagner, B | 1 |
Fenner, H | 1 |
Brune, K; Geisslinger, G; Krebs, S; Lötsch, J; Muth-Selbach, U; Tegeder, I | 1 |
Di Giamberardino, M; Panara, MR; Patrignani, P; Patrono, C; Renda, G; Rotondo, MT; Santini, G; Sciulli, MG; Seta, F; Tacconelli, S | 1 |
Arakida, Y; Honda, K; Miyata, K; Ohga, K; Suwa, K; Yamada, T; Yokota, M | 1 |
de Meijer, A; de Metz, M; Novakova, I; Thomas, C; Verbruggen, B; Vollaard, H | 1 |
Geisslinger, G; Gühring, H; Neupert, W; Tegeder, I | 1 |
Arakida, Y; Morio, H; Ohga, K; Okada, Y; Suwa, K; Yamada, T; Yokota, M | 1 |
Carballosa Coré-Bodelier, VM; Van Delft, JL; van Haeringen, NJ; van Sorge, AA | 1 |
Arnout, J; Buntinx, A; Dallob, A; De Lepeleire, I; De Schepper, PJ; Depré, M; Ebel, DL; Gertz, BJ; Schwartz, JI; Tanaka, W; Van Hecken, A; Wong, PH; Wynants, K | 1 |
Bond, R; Cook, J; Gilkeson, G; Guyton, K; Halushka, P; Reilly, C | 1 |
Chang, DM; Hsieh, TC; Hsu, CT; Kuo, SY; Young, TH | 1 |
Harada, K; Inoue, T; Nagakura, N; Oketani, K | 1 |
Inoue, T; Murakami, M; Oketani, K | 1 |
Goto, T; Ochi, T | 1 |
Kalsbeek-Batenburg, EM; Knijff-Dutmer, EA; Koerts, J; van de Laar, MA | 1 |
Murakami, M; Murota, M; Oketani, K; Sakai, H; Suzuki, T; Takeguchi, N; Uchiumi, T | 1 |
de Metz, M; Hovestad-Witterland, AH; van Kraaij, DJ; Vollaard, EJ | 1 |
Gagnier, RP; Rinder, HM; Souhrada, M; Tracey, JB; Wang, C; Wood, CC | 1 |
Budsberg, SC; Harmon, BG; Jones, CJ; Streppa, HK | 1 |
Al-Awadi, FM; Anim, JT; Haridas, S; Khan, I; Thomas, N | 1 |
Alcaro, S; De Luca, G; Maccari, R; Miceli, N; Monforte, F; Monforte, MT; Ortuso, F; Ottanà, R; Taviano, MF; Trovato, A; Vigorita, MG | 1 |
Ashton, S; Cook, J; Gilkeson, G; Guyton, K; Halushka, P; Reilly, C; Tempel, G; Teti, G; Zingarelli, B | 1 |
Feifel, U; Hanft, G; Kink-Eiband, M; Kuritsch, I; Pairet, M; Trummlitz, G; Van Ryn, J; Wallenstein, G | 1 |
Giraudel, JM; Lees, P; Toutain, PL | 1 |
Beretta, C; Cavalli, M; Garavaglia, G | 1 |
Friton, GM; Schmidt, H; Schrödl, W | 1 |
Dahlén, SE; Kumlin, M; Låstbom, L; Ryrfeldt, A; Selg, E | 1 |
Bertilsson, L; Hynninen, VV; Korhonen, T; Kurkinen, KJ; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
Borer, L; Jung, M; King, JN; Lees, P; Rudaz, C; Seewald, W | 1 |
Langston, VC; Lunsford, KV; Mackin, AJ; McLaughlin, RM; Mullins, KB; Pinchuk, LM; Thomason, JM; Wills, RW | 1 |
Al-Nadaf, S; Brainard, BM; Budsberg, SC; Cathcart, CJ; Reynolds, LR | 1 |
Abe, S; Honma, S; Mitazaki, S; Nakamura, K; Shinohara, M; Takahashi, N; Yoshida, M | 1 |
Bae, JW; Byeon, JY; Choi, CI; Jang, CG; Lee, HI; Lee, SY; Lee, YJ | 2 |
Fet, N; Hata, K; Klinge, U; Minor, T; Nakajima, A; Okamura, Y; Taura, K; Tolba, RH; Uchinami, H; Yamamoto, Y; Yamaoka, Y; Yonezawa, K | 1 |
Suarez-Kurtz, G | 1 |
Alexandre, EM; Antunes, E; Lescano, CH; Mendes-Silvério, CB; Mónica, FZ | 1 |
1 review(s) available for thiazoles and thromboxane b2
Article | Year |
---|---|
Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Meloxicam; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Substrate Specificity; Thiazines; Thiazoles; Thromboxane B2 | 1997 |
14 trial(s) available for thiazoles and thromboxane b2
Article | Year |
---|---|
Pharmacokinetics and cyclooxygenase inhibition of itazigrel in normal volunteers after single oral doses.
Topics: Administration, Oral; Adolescent; Adult; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukotriene B4; Male; Middle Aged; Single-Blind Method; Thiazoles; Thromboxane B2 | 1994 |
Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; Indomethacin; Meloxicam; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Therapeutic Equivalency; Thiazines; Thiazoles; Thromboxane B2 | 1997 |
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
Topics: Adult; Blood Platelets; Cross-Over Studies; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; In Vitro Techniques; Isoenzymes; Male; Meloxicam; Membrane Proteins; Monocytes; Prostaglandin-Endoperoxide Synthases; Thiazines; Thiazoles; Thromboxane B2 | 1999 |
Meloxicam, 15 mg/day, spares platelet function in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Blood Platelets; Cross-Over Studies; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Male; Meloxicam; Platelet Aggregation; Radioimmunoassay; Reference Values; Thiazines; Thiazoles; Thromboxane B2; Time Factors | 1999 |
Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers.
Topics: Adolescent; Adult; Bleeding Time; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Female; Humans; Ibuprofen; Isoenzymes; Lactones; Lipopolysaccharides; Meloxicam; Membrane Proteins; Middle Aged; Naproxen; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Sulfones; Thiazines; Thiazoles; Thromboxane B2 | 2000 |
Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis.
Topics: Adult; Aged; Arachidonic Acid; Cyclooxygenase Inhibitors; Digestive System; Dinoprostone; Double-Blind Method; Endoscopy, Digestive System; Female; Gastric Juice; Humans; Leukotriene B4; Male; Meloxicam; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Piroxicam; Safety; Thiazines; Thiazoles; Thromboxane B2 | 2001 |
Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Bleeding Time; Blood Platelets; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Meloxicam; Middle Aged; Naproxen; Platelet Aggregation; Random Allocation; Thiazines; Thiazoles; Thromboxane B2 | 2002 |
A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Butanones; Cross-Over Studies; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Isoenzymes; Male; Meloxicam; Membrane Proteins; Nabumetone; Prostaglandin-Endoperoxide Synthases; Thiazines; Thiazoles; Thromboxane B2 | 2002 |
Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bleeding Time; Blood Coagulation; Blood Platelets; Double-Blind Method; Female; Hemorrhage; Humans; Indomethacin; Male; Meloxicam; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Prothrombin Time; Thiazines; Thiazoles; Thromboxane B2 | 2002 |
Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers.
Topics: Adult; Aspirin; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Female; Humans; Isoenzymes; Male; Meloxicam; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Thiazines; Thiazoles; Thromboxane B2 | 2004 |
Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam.
Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Immunoglobulin G; Lipopolysaccharides; Male; Meloxicam; Single-Blind Method; Swine; Swine Diseases; Thiazines; Thiazoles; Thromboxane B2; Treatment Outcome | 2006 |
Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Blood Coagulation; Cross-Over Studies; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Drug Interactions; Genotype; Half-Life; Humans; Itraconazole; Male; Meloxicam; Protein Binding; Pyrimidines; Thiazines; Thiazoles; Thromboxane B2; Triazoles; Voriconazole; Young Adult | 2009 |
Effects of carprofen, meloxicam and deracoxib on platelet function in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Carbazoles; Dogs; Female; Hemostasis; Meloxicam; Platelet Aggregation; Sulfonamides; Thiazines; Thiazoles; Thromboxane B2 | 2012 |
Lack of inhibitory effect of acetylsalicylic acid and meloxicam on whole blood platelet aggregation in cats.
Topics: Animals; Aspirin; Cats; Cross-Over Studies; Male; Meloxicam; Platelet Aggregation; Thiazines; Thiazoles; Thromboxane B2 | 2012 |
31 other study(ies) available for thiazoles and thromboxane b2
Article | Year |
---|---|
(Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.
Topics: Administration, Oral; Animals; Chemical Phenomena; Chemistry; Enzyme Inhibitors; Guinea Pigs; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Mice; Naphthalenes; Rats; Structure-Activity Relationship; Thiazoles; Thromboxane B2 | 1991 |
Pharmacological profile of 48740 R.P., a PAF-acether antagonist.
Topics: Animals; Blood Cell Count; Blood Platelets; Bronchodilator Agents; Guinea Pigs; Humans; In Vitro Techniques; Macrophages; Male; Muscle Contraction; Muscle, Smooth; N-Formylmethionine Leucyl-Phenylalanine; Perfusion; Platelet Activating Factor; Platelet Aggregation; Pulmonary Alveoli; Pyridines; Rabbits; Radioimmunoassay; Superoxides; Thiazoles; Thromboxane B2 | 1988 |
[The effect of a specific antagonist of PAF (CV-3988) on airway hyperresponsiveness induced by ozone exposure in beagles].
Topics: Animals; Bronchi; Dogs; Female; Methacholine Chloride; Methacholine Compounds; Ozone; Phospholipid Ethers; Platelet Activating Factor; Thiazoles; Thromboxane B2 | 1987 |
CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen.
Topics: Animals; Blood Pressure; Collagen; Male; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Rabbits; Rats; Species Specificity; Thiazoles; Thromboxane B2; Time Factors | 1986 |
Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119.
Topics: Animals; Cebus; Indomethacin; Lung; Macaca mulatta; Male; Papio; Platelet Activating Factor; Platelet Aggregation; Thiazoles; Thrombocytopenia; Thromboxane B2 | 1986 |
Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
Topics: Animals; Blood Platelets; Cells, Cultured; Colitis; Dinoprostone; Disease Models, Animal; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Male; Peritoneal Cavity; Rats; Rats, Inbred F344; Sheep; Structure-Activity Relationship; Thiazoles; Thromboxane B2; Thromboxane-A Synthase | 1994 |
Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
Topics: Animals; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Lipopolysaccharides; Lung; Peroxidase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Stroke Volume; Swine; Thiazoles; Thromboxane B2; Vascular Resistance | 1996 |
Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state.
Topics: Administration, Oral; Adult; Area Under Curve; Cyclooxygenase Inhibitors; Diclofenac; Humans; Male; Meloxicam; Reference Values; Therapeutic Equivalency; Thiazines; Thiazoles; Thromboxane B2 | 1999 |
Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs.
Topics: Administration, Oral; Animals; Asthma; Chromones; Disease Models, Animal; Guinea Pigs; Immunization, Passive; Leukotriene Antagonists; Leukotrienes; Male; Membrane Proteins; Phenylacetates; Receptors, Leukotriene; Receptors, Thromboxane; Serum Albumin, Bovine; Sulfonamides; Tetrazoles; Thiazoles; Thromboxane A2; Thromboxane B2 | 1999 |
Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cyclooxygenase Inhibitors; Diclofenac; Dinoprost; Dose-Response Relationship, Drug; Ketorolac; Kidney; Lung; Male; Meloxicam; Nitrobenzenes; Prostaglandins; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiazines; Thiazoles; Thromboxane B2 | 2000 |
Effect of combined leukotriene D(4) and thromboxane A(2) receptor antagonist on mediator-controlled resistance in guinea pigs.
Topics: Administration, Oral; Airway Resistance; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Asthma; Benzoquinones; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Heptanoic Acids; Indomethacin; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Leukotriene E4; Lipid Metabolism; Lung; Male; Membrane Proteins; Ovalbumin; Receptors, Leukotriene; Receptors, Thromboxane; Tetrazoles; Thiazoles; Thromboxane B2; Time Factors | 2000 |
Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Calcimycin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Escherichia coli; Flurbiprofen; Humans; Isoenzymes; Lipopolysaccharides; Meloxicam; Membrane Proteins; Monocytes; Ophthalmic Solutions; Prostaglandin-Endoperoxide Synthases; Stereoisomerism; Thiazines; Thiazoles; Thromboxane B2 | 2000 |
Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Topics: Animals; Cyclopentanes; DNA-Binding Proteins; Enzyme Activation; Epoprostenol; I-kappa B Proteins; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-KappaB Inhibitor alpha; Nitric Oxide; Phosphorylation; Prostaglandin D2; Protein Processing, Post-Translational; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Thromboxane B2; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Topics: Animals; Arachidonate 5-Lipoxygenase; Benzothiazoles; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Humans; Hydroxyurea; Indomethacin; Leukocytes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mesalamine; Methacrylates; Neutrophils; Peritoneal Cavity; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Inbred F344; Sheep; Sulfasalazine; Thiazoles; Thromboxane B2; Thromboxane-A Synthase | 2001 |
Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide.
Topics: Animals; Benzothiazoles; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Gastrointestinal Agents; Injections, Intravenous; Intestinal Mucosa; Intestine, Large; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Prednisolone; Pyridines; Rats; Rats, Inbred F344; Sulfasalazine; Thiazoles; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 2001 |
Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis.
Topics: Adjuvants, Immunologic; Animals; Arthritis, Experimental; Chronic Disease; Collagen; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Edema; Female; Hindlimb; Isoenzymes; Membrane Proteins; Piperazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Thiazoles; Thromboxane B2 | 2002 |
E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon.
Topics: Animals; Benzothiazoles; Chlorides; Colon; Enzyme Inhibitors; Female; In Vitro Techniques; Intestinal Mucosa; Lipoxygenase Inhibitors; Organic Anion Transporters; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Wistar; Thiazoles; Thromboxane B2; Thromboxane-A Synthase | 2002 |
In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs.
Topics: Animals; Aspirin; Cross-Over Studies; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Dog Diseases; Dogs; Gastric Mucosa; Isoenzymes; Male; Meloxicam; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Stifle; Synovial Fluid; Thiazines; Thiazoles; Thromboxane B2 | 2002 |
Cyclooxygenase-2 inhibition and experimental colitis: beneficial effects of phosphorothioated antisense oligonucleotide and meloxicam.
Topics: Animals; Colitis; Colon; Cyclooxygenase Inhibitors; Dinoprostone; Male; Meloxicam; Oligonucleotides, Antisense; Peroxidase; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazines; Thiazoles; Thromboxane B2; Tumor Necrosis Factor-alpha | 2002 |
Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Lipopolysaccharides; Membrane Proteins; Models, Molecular; Monocytes; Prostaglandin-Endoperoxide Synthases; Protein Conformation; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity; Thiazoles; Thromboxane B2 | 2003 |
Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Topics: Animals; Cells, Cultured; Chromans; Enzyme Activation; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; I-kappa B Proteins; Inflammation Mediators; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mitogen-Activated Protein Kinases; Nitric Oxide; Phosphorylation; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Staphylococcus aureus; Thiazoles; Thiazolidinediones; Thromboxane B2; Transcription Factors; Troglitazone | 2003 |
Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cats; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Inhibitory Concentration 50; Male; Meloxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Radioimmunoassay; Thiazines; Thiazoles; Thromboxane B2 | 2005 |
COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Clonixin; Cyclooxygenase Inhibitors; Dinoprostone; Female; Horses; In Vitro Techniques; Male; Meloxicam; Phenylbutazone; Thiazines; Thiazoles; Thromboxane B2 | 2005 |
Effects of selective and non-selective COX inhibitors on antigen-induced release of prostanoid mediators and bronchoconstriction in the isolated perfused and ventilated guinea pig lung.
Topics: Animals; Bronchoconstriction; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diclofenac; Flurbiprofen; Guinea Pigs; Humans; Leukotrienes; Lung; Male; Ovalbumin; Piperazines; Prostaglandins; Pyrazoles; Sulfonamides; Thiazoles; Thromboxane A2; Thromboxane B2 | 2008 |
In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Etodolac; Isoenzymes; Ketoprofen; Kinetics; Lipopolysaccharides; Meloxicam; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thiazines; Thiazoles; Thromboxane B2 | 2010 |
Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.
Topics: Animals; Cisplatin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Gene Expression Regulation, Enzymologic; Kidney; Macrophages; Male; Meloxicam; Mice; Mice, Inbred BALB C; Oxidative Stress; Thiazines; Thiazoles; Thromboxane B2 | 2013 |
Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2C9; Genetic Variation; Genotype; Humans; Male; Meloxicam; Metabolic Clearance Rate; Polymorphism, Genetic; Thiazines; Thiazoles; Thromboxane B2 | 2014 |
Role of preferential cyclooxygenase-2 inhibition by meloxicam in ischemia/reperfusion injury of the rat liver.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Gadolinium; In Situ Nick-End Labeling; Kidney Function Tests; Kupffer Cells; Liver; Liver Diseases; Male; Meloxicam; Rats, Wistar; Reperfusion Injury; Thiazines; Thiazoles; Thromboxane B2; Tumor Necrosis Factor-alpha | 2014 |
Impact of CYP2C9*3/*3 genotype on the pharmacokinetics and pharmacodynamics of oxicam NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Humans; Male; Thiazines; Thiazoles; Thromboxane B2 | 2014 |
Response to Suarez-Kurtz's comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Humans; Male; Thiazines; Thiazoles; Thromboxane B2 | 2014 |
Mirabegron, a β
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Biological Transport; Calcium; Cyclic AMP; Humans; Platelet Aggregation; Receptors, Adrenergic, beta-3; Thiazoles; Thromboxane B2 | 2018 |